Critical roles of CRIP1 in promoting cell survival and bortezomib resistance by enhancing proteasome activity and autophagy in multiple myeloma

被引：0
|
作者：
Yu, Zhen [1 ,2 ]
Tang, Peixia [1 ,2 ]
Xu, Zhenshu [3 ]
Hao, Mu [1 ,2 ]
Qiu, Lugui [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin 300020, Peoples R China
[3] Fujian Med Univ, Union Hosp, Fujian Inst Hematol, Hematol Dept, Fuzhou, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA-30
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 50 条
  • [1] CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy
    Tang, Peixia
    Yu, Zhen
    Sun, Hao
    Liu, Lanting
    Gong, Lixin
    Fang, Teng
    Sun, Xiyue
    Xie, Shiyi
    An, Gang
    Xu, Zhenshu
    Qiu, Lugui
    Hao, Mu
    EBIOMEDICINE, 2024, 100
  • [2] CRIP1 Involves the Pathogenesis of Multiple Myeloma Via Dual-Regulation of Proteasome and Autophagy
    Yu, Zhen
    Tang, Peixia
    Xu, Zhenshu
    Qiu, Lugui
    Hao, Mu
    BLOOD, 2023, 142
  • [3] NEK2 Promotes Bortezomib Resistance through Enhancing Autophagy By Upregulation of Beclin1 in Multiple Myeloma Cells
    Xia, Jiliang
    He, Yanjuan
    Meng, Bin
    Zhang, Jingyu
    Wu, Xuan
    Feng, Xiangling
    Kuang, Chunmei
    Guo, Jiaojiao
    Lei, Qian
    Guan, Yongjun
    Shen, Yi
    Qiu, Lugui
    Zhou, Wen
    BLOOD, 2019, 134
  • [4] Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
    de la Puente, Pilar
    Luderer, Micah J.
    Federico, Cinzia
    Jin, Abbey
    Gilson, Rebecca C.
    Egbulefu, Christopher
    Alhallak, Kinan
    Shah, Shruti
    Muz, Barbara
    Sun, Jennifer
    King, Justin
    Kohnen, Daniel
    Salama, Noha Nabil
    Achilefu, Samuel
    Vij, Ravi
    Azab, Abdel Kareem
    JOURNAL OF CONTROLLED RELEASE, 2018, 270 : 158 - 176
  • [5] BORTEZOMIB-RESISTANCE OF BONE MARROW FIBROBLASTS IN MULTIPLE MYELOMA IS CLOSELY CONNECTED TO ACTIVATION OF AUTOPHAGY AS SURVIVAL MACHINERY
    Di Marzo, L.
    Desantis, V.
    Vergara, D.
    De Veirman, K.
    Catacchio, I.
    Rao, L.
    Maffia, M.
    Vanderkerken, K.
    Vacca, A.
    Frassanito, M. A.
    HAEMATOLOGICA, 2015, 100 : 248 - 248
  • [6] Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
    Roy, Mridul
    Liang, Long
    Xiao, Xiaojuan
    Peng, Yuanliang
    Luo, Yuhao
    Zhou, Weihua
    Zhang, Ji
    Qiu, Lugui
    Zhang, Shuaishuai
    Liu, Feng
    Ye, Mao
    Zhou, Wen
    Liu, Jing
    THERANOSTICS, 2016, 6 (12): : 2209 - 2224
  • [7] Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma
    Roy, Mridul
    Liang, Long
    Xiao, Xiaojuan
    Peng, Yuanliang
    Luo, Yuhao
    Zhou, Weihua
    Zhang, Ji
    Qiu, Lugui
    Zhang, Shuaishuai
    Liu, Feng
    An, Xiuli
    Ye, Mao
    Zhou, Wen
    Liu, Jing
    BLOOD, 2016, 128 (22)
  • [8] Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1
    Li, Hui
    Roy, Mridul
    Liang, Long
    Cao, Wenjie
    Hu, Bin
    Li, Yanan
    Xiao, Xiaojuan
    Wang, Haiqin
    Ye, Mao
    Sun, Shuming
    Zhang, Bin
    Liu, Jing
    ONCOGENE, 2022, 41 (09) : 1298 - 1308
  • [9] Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1
    Hui Li
    Mridul Roy
    Long Liang
    Wenjie Cao
    Bin Hu
    Yanan Li
    Xiaojuan Xiao
    Haiqin Wang
    Mao Ye
    Shuming Sun
    Bin Zhang
    Jing Liu
    Oncogene, 2022, 41 : 1298 - 1308
  • [10] Mechanisms of activity and drug resistance with proteasome inhibitors in multiple myeloma: Comparison of bortezomib and the investigational drug MLN9708
    Bianchi, Giada
    Ramakrishnan, Vijay G.
    Kimlinger, Teresa K.
    Haug, Jessica
    Rajkumar, S. Vincent
    Kumar, Shaji
    CANCER RESEARCH, 2012, 72
12345